"Dr. Mark J. Weiss specializes in the treatment of glaucoma. Glaucoma is a dangerous eye disease that's caused by increased pressure within the eye. If left untreated, this serious condition can lead to blindness. Fortunately, there are many methods of treatment, including medicated eye drops, laser treatments, and surgery. While these methods don't cure glaucoma, they can effectively control the pressure within the eye and preserve the patient’s eyesight. Dr. Weiss combines his vast experience in glaucoma treatment with his personal caring approach to provide his patients with the best care possible. In addition to caring for his glaucoma patients, he enjoys seeing patients for general ophthalmological care, including routine eye exams."

During the past decade, Mark J. Weiss, MD. Inc. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mark J. Weiss, MD. Inc." are "Ocular Hypertension" (3 trials), "Primary Open Angle Glaucoma" (2 trials), "Glaucoma" (1 trials), "Glaucoma and Ocular Hypertension" (1 trials) and "Primary Open-Angle Glaucoma" (1 trials). Many other conditions were trialed in "Mark J. Weiss, MD. Inc." in a lesser frequency.

Most popular intervention types in "Mark J. Weiss, MD. Inc." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "AKB-9778" (1 trials), "DE-117 Ophthalmic Solution" (1 trials), "DE-126 Ophthalmic Solution 0.002% QD" (1 trials), "Latanoprost 0.005%" (1 trials) and "Latanoprost Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mark J. Weiss, MD. Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mark J. Weiss, MD. Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mark J. Weiss, MD. Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mark J. Weiss, MD. Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".